SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-006547
Filing Date
2022-04-28
Accepted
2022-04-28 16:20:09
Documents
16
Period of Report
2022-04-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nktx-20220428.htm   iXBRL 8-K 68669
2 EX-1.1 nktx-ex1_1.htm EX-1.1 420623
3 EX-5.1 nktx-ex5_1.htm EX-5.1 21946
4 GRAPHIC img264793915_0.jpg GRAPHIC 18129
5 GRAPHIC img264793915_1.jpg GRAPHIC 18129
  Complete submission text file 0000950170-22-006547.txt   757826

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktx-20220428_pre.xml EX-101.PRE 11594
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktx-20220428_lab.xml EX-101.LAB 18598
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktx-20220428.xsd EX-101.SCH 2488
10 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20220428_htm.xml XML 4889
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39370 | Film No.: 22866913
SIC: 2834 Pharmaceutical Preparations